(Q50767407)

18 March 2018

title

"In vitro" evaluation of bone marrow angiogenesis in myelodysplastic syndromes: a morphological and functional approach. (English)

1 reference

18 March 2018

author

Diana Campioni

1

1 reference

18 March 2018

author name string

Marina Punturieri

2

1 reference

18 March 2018

Antonella Bardi

3

1 reference

18 March 2018

Sabrina Moretti

4

1 reference

18 March 2018

Elisa Tammiso

5

1 reference

18 March 2018

Francesco Lanza

6

1 reference

18 March 2018

Gianluigi Castoldi

7

1 reference

18 March 2018

publication date

1 January 2004

1 reference

18 March 2018

published in

Leukemia Research

1 reference

18 March 2018

volume

28

1 reference

18 March 2018

issue

1

1 reference

18 March 2018

page(s)

9-17

1 reference

18 March 2018

cites work

Clinical features of MDS

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Stromal abnormalities in neoplastic bone marrow diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndrome (MDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Marrow stroma in MDS: culprit or bystander?

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Prognostic evaluation of the microvascular network in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Bone marrow angiogenesis and progression in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Angiogenesis in chronic myeloproliferative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Expression of endothelial cell-associated molecules in AML cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Angiogenesis in multiple myeloma: correlation between in vitro endothelial colonies growth (CFU-En) and clinical–biological features

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Angiogenesis and angiogenic mediators in haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Human bone marrow angiogenesis: in vitro modulation by substance P and neurokinin A

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Extensive apoptosis of bone marrow cells as evaluated by the in situ end-labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

The dilemma of apoptosis in myelodysplasia and leukemia: a new promise of therapeutic intervention?

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

Less apoptosis in patients with 5q-syndrome than in patients with refractory anemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2803%2900123-1

7 January 2021

10.1016/S0145-2126(03)00123-1

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018